Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-Analysis of Prospective Studies

Abstract

Objective.-To estimate the incidence of serious and fatal adverse drug reactions (ADR) in hospital patients.Data Sources.-Four electronic databases were searched from 1966 to 1996. Study Selection.-Of 153, we selected 39 prospective studies from US hospitals.Data Extraction.-Data extracted independently by 2 investigators were analyzed by a random-effects model. To obtain the overall incidence of ADRs in hospitalized patients, we combined the incidence of ADRs occurring while in the hospital plus the incidence of ADRs causing admission to hospital. We excluded errors in drug administration, noncompliance, overdose, drug abuse, therapeutic failures, and possible ADRs. Serious ADRs were defined as those that required hospitalization, were permanently disabling, or resulted in death.Data Synthesis.-The overall incidence of serious ADRs was 6.7% (95% confidence interval [CI], 5.2%-8.2%) and of fatal ADRs was 0.32% (95% CI, 0.23%-0.41%) of hospitalized patients. We estimated that in 1994 overall 2 216 000 (1 721 000-2 711 000) hospitalized patients had serious ADRs and 106 000 (76 000-137 000) had fatal ADRs, making these reactions between the fourth and sixth leading cause of death.Conclusions.-The incidence of serious and fatal ADRs in US hospitals was found to be extremely high. While our results must be viewed with circumspection because of heterogeneity among studies and small biases in the samples, these data nevertheless suggest that ADRs represent an important clinical issue.

Different Black Box Warning Labeling for Same-Class Drugs

“…[1][2][3][4] Black box warnings (BBWs) are the strongest medication-related safety warnings that can be placed in a drug's labeling information according to the Food and Drug Administration (FDA) 5 and highlight major drug-related risks. 6 Based on evidence from animal, clinical, or post-marketing surveillance studies and reports, the FDA decides whether acquisition and/or updating of a BBW is required.…”

Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions

“…3 During 1994, ADRs affected over 2 million people in the United States, resulting in over 100 000 deaths. 4 In 2002, ADRs accounted for 6.5% of hospital admissions and 0.15% of subsequent deaths in the United Kingdom. 5 Thus, patients, the medical community, health-care providers, regulatory agencies and the pharmaceutical industry have a compelling interest to identify factors that influence ADR risk.…”

The need for organizational change in patient safety initiatives

“…A significant number of these errors involve medi- cations. A meta-analysis of 39 prospective studies indicated that adverse drug reactions may rank between the fourth and seventh leading cause of deaths in the U.S. [3]. One study of medication errors in 36 hospitals and skilled nursing facilities in Georgia and Colorado found that 19% of the doses were in error; 7% of the errors could have resulted in adverse drug events [4].…”